Researchers to test new drug found to prevent malaria among pregnant women

Pregnant Woman

Scientists have advanced the search for a safer drug that will be used to prevent and manage malaria in pregnant women.

Researchers at the Kenya Medical Research Institute (Kemri) have identified an anti-malarial drug, dihydroartemisinin-piperaquine (DP), as a viable option to replace fansidar (sulphadoxine and pyrimethamine, also known as SP), which is currently being used to prevent malaria in pregnancy.